Showing results (11-20 of 365) with videos related to
Sort By:
Pageof 37
Endocrine, Metabolic & Immune Disorders Drug Targets|November 19, 2017
Olive Oil-related Anti-inflammatory Effects on Atherosclerosis: Potential Clinical ImplicationsTanakal Wongwarawipat, Nikolaos Papageorgiou, Dimitrios Bertsias, et al.Current Opinion in Pharmacology|February 23, 2018
Peripheral artery disease and antiplatelet treatmentVasiliki Tsigkou, Gerasimos Siasos, Kleanthis Rovos, et al.Current Pharmaceutical Design|August 18, 2017
Statins in acute coronary syndromesManolis Vavuranakis, Maria Kariori, Gerasimos Siasos, et al.Current Opinion in Pharmacology|April 22, 2018
Peripheral artery disease: a micro-RNA-related condition?Georgia Vogiatzi, Evangelos Oikonomou, Spyridon Deftereos, et al.International Journal of Cardiology|July 25, 2006
L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?Gerasimos Siasos, Dimitris Tousoulis, Charalambos Antoniades, et al.Current Pharmaceutical Design|December 23, 2015
Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main ContributorsMarianne Karamanou, Athanase Protogerou, Gerasimos Siasos, et al.Current Opinion in Pharmacology|February 21, 2018
Anti-hypertensive treatment in peripheral artery diseaseCostas Tsioufis, Ioannis Andrikou, Gerasimos Siasos, et al.International Immunopharmacology|April 4, 2020
Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapyMaria V Deligiorgi, Gerasimos Siasos, Chrysovalantis Vergadis, et al.Journal of Interventional Cardiology|December 13, 2005
Intracoronary thermography: does it help us in clinical decision making?Konstantinos Toutouzas, Maria Drakopoulou, Elli Stefanadi, et al.Current Pharmaceutical Design|June 14, 2016
P2Y12 Receptor Antagonists: Which One to Choose? A Systematic Review and Meta-AnalysisAlexandros Briasoulis, Tesfaye Telila, Mohan Palla, et al.Pageof 37